Stockholm, Sweden

Osman Ahmed

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Lipoprotein Research Stockholm Ab, The Kitasato Institute. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Osman Ahmed. Retrieved from https://idiyas.com/inventor/osman-ahmed-vkb35qz2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Osman Ahmed: Innovator in PCSK9 Inhibition

Introduction

Osman Ahmed is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit proprotein convertase subtilisin/kexin type 9 (PCSK9). His work is crucial in addressing various health issues related to cholesterol regulation.

Latest Patents

Osman Ahmed holds a patent for a low-molecular weight compound that acts as a PCSK9 inhibitor. This patent, titled "Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor and pharmaceutical use therefor," describes a compound that inhibits the functions of PCSK9. The patent outlines the use of this compound, along with its pharmaceutically acceptable salts or solvates, in the prevention or treatment of diseases related to PCSK9 functions. He has 1 patent to his name.

Career Highlights

Throughout his career, Osman Ahmed has worked with esteemed organizations such as The Kitasato Institute and Lipoprotein Research Stockholm AB. His experience in these institutions has allowed him to advance his research and contribute to the scientific community effectively.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Osman Ahmed's innovative work in developing PCSK9 inhibitors showcases his dedication to improving health outcomes through pharmaceutical advancements. His contributions are vital in the ongoing fight against cholesterol-related disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…